WeightWatchers is buying digital health company Sequence to capitalize on the hot market for diabetes and weight loss drugs including Ozempic and Wegovy. WSJ's Andrea Petersen explains what this could mean for the wellness industry.
-WeightWatchers Moves Into the Ozempic Market With Telehealth Deal
-How a Diabetes Drug Became the Talk of Hollywood, Tech and the Hamptons
-Health Startups Offer Diabetes Drugs Like Ozempic for Weight Loss With Little Oversight
Today, Apple released its Vision Pro headset, the company’s first major new product launch in a decade. WSJ’s Joanna Stern on whether the augmented-reality headset has the potential to take a niche device for nerds into the mainstream.
Artem Uss is a Kremlin-linked businessman accused of illegally exporting American military technology to Russia. Last October he was arrested in Italy at the U.S.’s request. Then he vanished. WSJ’s Margherita Stancati explains how he escaped.